NCT05299814 Impact of Parental Emotion Regulation on the Treatment of ADHD
| NCT ID | NCT05299814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 65 participants |
| Start Date | 2017-04-13 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 65 participants in total. It began in 2017-04-13 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim: To examine if parental emotion regulation (ER) moderates the response to parent training interventions. H1: Reduced parental ER capacity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD. H2: Increased parental emotional reactivity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD.
Eligibility Criteria
Inclusion Criteria: * Parent of a child ages 5-12 with ADHD * Parent must report that the child has at least a mild level of symptoms at home of Oppositional Defiant Disorder (ODD) on the Disruptive Behavior Disorder Rating Scale (DBDRS) Exclusion Criteria: 1. Not being the parent of a child ages 5-12 who meets diagnostic criteria for ADHD. 2. Non English Speaking 3. the child with ADHD has a diagnosis of intellectual delay or has prominent autistic traits 4. Another child in the same family participating in this study already 5. Parent does not have a smartphone or tablet device to complete EMA ratings or does not reside with child for the majority of the time.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05299814 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 12 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05299814 currently recruiting?
Yes, NCT05299814 is actively recruiting participants. Contact the research team at jwaxmonsky@pennstatehealth.psu.edu for enrollment information.
Where is the NCT05299814 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT05299814 clinical trial?
NCT05299814 is sponsored by Milton S. Hershey Medical Center. The trial plans to enroll 65 participants.